Tykerb 250mg Tablet

Prescription Required

Manufactured By

glaxo smithkline pharmaceuticals

Pack of

30 Tablets

Salt Composition

Lapatinib

Storage

Keep in cold place

shipping-zone

Delivering To:

Overview

Lapatinib 250mg tablet is used in the treatment of Breast cancer. It belongs to a class of medications known as antineoplastics. This medicine works by slowing or stopping the growth of cancer cells. It is important to take this medicine as prescribed by your doctor. The recommended dose of Tykerb tablet is decided by a doctor according to your previous medical condition and response to the treatment.  

Indication

Breast Cancer

Ratings And Reviews

0.00/5

0

0 Ratings

5

0.00%

4

0.00%

3

0.00%

2

0.00%

1

0.00%

Description

Lapatinib is a small molecule and a member of the 4-anilinoquinazoline class of kinase inhibitors. It retained significant activity against breast cancer cell lines selected for long-term growth in the trastuzumab-containing medium in vitro. These in vitro findings suggest non–cross-resistance between these two agents. Hormone receptor-positive breast cancer cells (with ER [Estrogen Receptor] and PgR [Progesterone Receptor]) that coexpress the HER2 tend to be resistant to established endocrine therapies. Similarly, hormone receptor-positive breast cancer cells that initially lack EGFR or HER2 upregulate these receptor proteins as the tumor becomes resistant to endocrine therapy. 

Side Effects

Most side effects of Lapatinib 250mg tablet do not require medical attention as they may disappear as your body adjusts to the medicine. In case these side effects become worse, consult your doctor immediately.

Headache  

Abdominal pain  

Severe diarrhea  

Fatigue  

Nausea  

Constipation  

Stomatitis  

Weight gain  

Loss of appetite  

Rash  

Insomnia  

Liver damage  

Vomiting  

Breathing problems  

Cough  

Increased bilirubin in the blood  

Mucosal inflammation  

How To Use

Take Lapatinib 250mg tablet as prescribed by your doctor. Do not stop or skip your regular dosing schedule.  

​In case of an overdose of Lapatinib tablets, the doctor will provide emergency medical treatment. 

Safety Advice

Alcohol

Alcohol

unsafe

It is advisable not to consume alcohol while taking medicine.

Pregnancy

Pregnancy

consult your doctor

Do not take Lapatinib 250mg tablet without consulting the doctor, in case of pregnancy.

Breast Feeding

Breast Feeding

consult your doctor

Without a doctor's consultation, do not take this medicine if you're breastfeeding.

Driving

Driving

danger

It is advisable not to drive or operate heavy machinery, you may feel dizzy as one of the side effects of the medicine.

Kidney

Kidney

caution

Do not take Lapatinib 250mg tablet without a doctor's consultation in case of kidney problems.

Liver

Liver

caution

Share your medical history with the doctor in case of liver disease before taking this medicine.

Missed Doses

If you forget to take a dose of Lapatinib 250mg tablet, consult your doctor. Don’t double up the next dose to cope with the missed one unless your doctor recommends it.

FAQs

What is Lapatinib 250mg Tablet ?

It is an anti-cancer medication that is used in the treatment of a certain type of Breast cancer (HER2-positive).  

What are the common side effects of Lapatinib tablets?

Some common side effects of Lapatinib tablets are joint pain, pale skin, dehydration, indigestion, constipation, headache, etc.  

Can I drive after taking this medicine?

This medicine may decrease your ability to drive, affect your vision, or make you feel sleepy. Do not drive if any symptoms occur. 

How does Lapatinib 250mg tablet work?

It works against the HER2 (human epidermal growth factor receptor protein) receptors and EGFRs (epidermal growth factor receptor) which are responsible for the over-proliferation of cells. This helps to stop the growth of cancer cells.  

Can I take Lapatinib 250mg tablet during pregnancy or breastfeeding?

This medicine is not recommended during pregnancy as it may harm the unborn baby.

Related Products

MARKETER DETAILS

glaxo smithkline pharmaceuticals